Item 8.01 Other Events.
CEO Letter to Shareholders
On June 21, 2021, Vitality Biopharma, Inc. (the "Company") posted on the
Company's website (www.vitality.bio) a letter from the Company's Chief Executive
Officer, Michael Cavanaugh, to the Company's shareholders. A copy of the letter
is filed as Exhibit 20.1 to this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits
Exhibit No. Description
20.1 Letter from Michael Cavanaugh to the Company's Shareholders
© Edgar Online, source Glimpses